BlackRock Institutional Trust’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

BlackRock Institutional Trust’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.4M	Buy	303,516 +30,811	+11%	+$127K	﹤0.01%	3183
2016 Q3	$1.16M	Buy	272,705 +11,027	+4%	+$35.7K	﹤0.01%	3239
2016 Q2	$628K	Buy	261,678 +64,604	+33%	+$234K	﹤0.01%	3445
2016 Q1	$926K	Sell	197,074 -1,029	-0.5%	-$3.98K	﹤0.01%	3302
2015 Q4	$779K	Buy	198,103 +15,726	+9%	+$72.5K	﹤0.01%	3393
2015 Q3	$706K	Buy	182,377 +108,846	+148%	+$500K	﹤0.01%	3427
2015 Q2	$338K	Buy	73,531 +63,702	+648%	+$611K	﹤0.01%	3566
2015 Q1	$66K	Buy	+9,829	New	+$48.7K	﹤0.01%	3738

Other funds holding AST

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Institutional Trust's AST Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Asterias Biotherapeutics Inc. Series A (AST) stake by 11% in Q4 2016, buying an estimated $127K and bringing the position to 303,516 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3183.

BlackRock Institutional Trust first reported a position in AST in Q1 2015 and has held it in 8 quarters since. 66 funds tracked by Wall St. Rank hold AST as of Q4 2016.

BlackRock Institutional Trust held 303,516 shares of Asterias Biotherapeutics Inc. Series A worth $1.4M as of Q4 2016.
BlackRock Institutional Trust bought 30,811 Asterias Biotherapeutics Inc. Series A shares in Q4 2016, an estimated $127K.
Asterias Biotherapeutics Inc. Series A made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3183 holding.
BlackRock Institutional Trust first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2015 and has held it in 8 quarters since.
66 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.